Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB- IVA mycosis fungoides/Sézary syndrome. - Child, F.; Ortiz ‐ Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; WeichENthal, M.; Alves, R.; Quaglino, P.; Beylot ‐ Barry, M.; Cowan, R.; Geskin, L.J.; Pérez ‐ Ferriols, A.; et al. (British Journal of Dermatology, 2016)